Skip to content

PLRZ

Polyrizon Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$11.24
−10.51%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue342.0K342.0K118.0K4.0K5.0K
Gross Profit(342.0K)(342.0K)(118.0K)(4.0K)(5.0K)
Operating Expenses
R&D Expense2.0M2.1M534.0K332.0K347.0K
SG&A Expense3.5M3.8M768.0K303.0K548.0K
General & Admin Expense1.2M768.0K303.0K533.0K
Selling & Marketing Expense15.0K
Other Expenses(5.0K)
Total Operating Expenses5.5M5.9M1.3M635.0K895.0K
Cost and Expenses6.2M6.2M1.3M635.0K895.0K
Operating Income (EBIT)(6.2M)(6.2M)(1.3M)(635.0K)(895.0K)
Non-Operating
Interest Income2.1M370.0K
Interest Expense4.7M3.1M3.0K2.0K2.0K
Net Interest Income(2.6M)(2.8M)(28.0K)(230.0K)(2.0K)
Other Non-Op Income/Expense2.9M2.9M(243.0K)35.0K116.0K
Non-Operating Income (excl Interest)5.0K240.0K(37.0K)(118.0K)
EBT (Pre-Tax Income)(3.3M)(3.3M)(1.5M)(600.0K)(779.0K)
Income Tax Expense
Bottom Line
Net Income(3.3M)(3.3M)(1.5M)(600.0K)(779.0K)
Earnings from Cont. Ops(3.3M)(3.3M)(1.5M)(600.0K)(779.0K)
Earnings from Discont. Ops
Bottom Line Net Income(4.7M)(3.3M)(1.6M)(669.0K)(823.0K)
Per Share
Basic EPS($3.49)($2.07)($134.14)$0.00$0.00
Diluted EPS($3.49)($2.07)($134.14)$0.00$0.00
Revenue Per Share$0.00$0.00$0.00
Shares
Basic Shares Outstanding1.6M1.6M11000
Diluted Shares Outstanding1.6M1.6M11965
Profitability Metrics
EBITDA(5.9M)(5.9M)(1.4M)(631.0K)(772.0K)
D&A342.0K342.0K118.0K4.0K5.0K
EBIT(6.2M)(6.2M)(1.5M)(635.0K)(777.0K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025